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Highlights 
 A total of 12,145 women were included for analysis from the Norfolk cohort of the 
European Prospective Investigation into Cancer (EPIC).  
 Gestational diabetes mellitus (GDM) was significantly associated with hip fractures 
after adjusting for potential confounding factors. 
 No other study has investigated the link between gestational diabetes mellitus and 













Gestational diabetes mellitus (GDM) is a common pregnancy complication. This study aims to 
investigate the association between a history of GDM and bone mineral density (BMD), 
fractures, and falls in later life. 
Study design 
We used data from the Norfolk cohort of the European Prospective Investigation into Cancer 
(EPIC-Norfolk) where BMD at calcaneum was measured at second health check (1997-2000) 
using broadband ultrasound attenuation (BUA) and velocity of sound (VOS) in 7,515 women. 
Fractures and falls were documented from hospital admissions data via linkage with ENCORE 
(East Norfolk Commission Record) and history of GDM from health questionnaires at baseline. 
We examined the relationship between GDM and BUA/VOS using linear regression. Cox 
regression was used to estimate hazard ratios (HRs) for incident fractures and falls, controlling 
for age, BMI, smoking status, physical activity, area deprivation, self-reported stroke, use of 
diuretics, calcium and vitamin D supplements, social class and education, statin and total 
blood cholesterol, prevalent diabetes, hormone therapy and menopausal status.   
Results 
History of GDM (n=183) was not statistically significantly associated with BUA/VOS in fully 
adjusted linear regression models with unstandardised beta coefficients (standard error): -
0.37 (1.40) and -5.41 (3.48). GDM was significantly (p<0.05) associated with risk of hip and all 
fractures, fully adjusted HRs(95%CI) 2.46(1.54-3.92) and 1.60(1.09-2.35), respectively. 
Median follow-up from first live birth to date of admission was 53 and 52 years, respectively. 
Conclusion 
There was an association between history of GDM and risk of any fracture as well as hip 
fracture specifically. Further research is required to confirm this.  
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Diabetes developed during pregnancy, gestational diabetes mellitus (GDM), has an estimated 
prevalence of around 8-24% in the UK according to a systematic review [1]. This has been 
attributed to several factors including increased incidence of obesity and diabetes mellitus 
(DM) among women of childbearing age as well as increasing maternal age at first pregnancy 
[2,3]. 
Indeed, GDM is amongst the commonest pregnancy complications along with gestational 
hypertension and preterm labour [4]. Furthermore, it is a recognised risk factor for 
development of T2DM, making it an important pregnancy related complication to identify and 
monitor in order to safeguard future health [5,6]. Examples of maternal and infant 
consequences of GDM previously reported include macrosomia in the baby and is also 
thought to contribute to BMD reduction [7,8]. However, to date future fracture and falls risk 
in women with GDM has not been investigated. 
Dual energy X-ray absorptiometry (DEXA) is utilised in clinical practice as the gold standard 
for diagnosis of osteoporosis. However, it is expensive and not always accessible. BMD 
measurement can be performed using different modalities. Peripheral sites can be measured 
with quantitative ultrasound (QUS) which is fast, portable, and feasible in a large sample. QUS 
of the calcaneus was reported to predict total and hip fracture risk in men and women in a 











Furthermore, some studies suggest usefulness of QUS in predicting osteoporosis in at-risk 
groups such as women with premature menopause [10].  
Osteoporosis is an escalating health problem, with fragility fractures accounting for over 
300,000 patients admitted to hospitals in the UK each year and 1.5 million in the US who are 
over 50 years of age [11,12]. A previous meta-analysis into the link between DM and BMD has 
demonstrated findings that type 1 DM decreases BMD while type 2 DM increases BMD [13]. 
Despite the difference in BMD there was still an increased hip fracture risk for both conditions 
[13]. However, to date there is a lack of evidence of long term sequalae of GDM regarding its 
association with future risk of osteoporosis, fractures, and falls. 
The aim of our study was to investigate the association between GDM with BMD, fractures, 




The study population was drawn from the Norfolk cohort of the European Prospective 
Investigation into Cancer (EPIC) which consisted of 30,000 men and women aged 39-79 at the 
baseline who resided in Norfolk, UK, recruited between 1993 and 1997. Follow-up and data 
collection were extended to allow assessment of other chronic diseases and their 
determinants. The recruitment and study methods have been detailed elsewhere [14]. The 
EPIC-Norfolk study was approved by the Norwich Research Ethics committee. 
Exposure assessment 
At the baseline (1993-1997), participants completed a detailed health and lifestyle 
questionnaire and attended the first clinic visit where lifestyle determinants of health were 
measured. From this questionnaire, the participants’ educational status, occupational social 
class, and physical activity were acquired. The main exposure of interest, GDM, was 
ascertained from the binary question of “Have you ever had diabetes during pregnancy?”. 
Educational status was recorded as no qualification, O-level, A-level, and degree. Social class 
was classified according to the Registrar General’s occupation-based classification scheme 
[15]. Physical activity was categorised into four groups as derived from the validated EPIC 
short physical activity questionnaire designed to evaluate combined work and leisure activity 
[16].  
Other information collected from the questionnaire included menopausal status 
(premenopausal, perimenopausal <1yr, perimenopausal for 1-5 years, and postmenopausal) 
and hormone therapy (HT) in women (current, former, never). Trained nurses examined 
participants for the clinical assessments and anthropometric measurements using 
standardised protocol. Weight was measured with participants wearing light clothing and 











removed. Body mass index (BMI) was calculated with the formula weight (Kg) divided by 
height squared (m2). From non-fasting venous blood samples, full lipid assay was performed, 
and serum total cholesterol was measured with the RA 1000 (Bayer Diagnostics, Basingstoke, 
UK).  
Nutritional status was derived from food frequency questionnaires (FFQ) answered at the 
baseline health check. Vitamin D, calcium, and protein were obtained and utilised from the 
FFQ in this study. Furthermore, vitamin D and calcium supplement use were recorded at the 
baseline health check.  
At the second health check (1997-2000), individuals were invited to attend the second clinic 
visit. Approximately 15,000 responded of those mailed after excluding participants that had 
moved or died. 
Medical history was ascertained on the health questionnaire repeated at the second health 
check (1997-2000) with the question “Has a doctor ever told you have any of the following?” 
followed by a list of conditions including stroke, cancer, and DM. Smoking status was 
determined from questions “Have you ever smoked as much as one cigarette a day for as long 
as a year?” and “Do you smoke cigarettes now?”. For current medications at baseline, 
participants were asked to report the medications (such as diuretics and statins) they were 
on (name, frequency, dose, etc). 
BMD outcomes 
At the second health check (1997-2000) broadband ultrasound attenuation 
(decibel/megahertz) and velocity of sound (metres/second) were quantified at each 
calcaneum at least twice using the CUBA sonometer (McCue Ultrasonics, Winchester, UK). 
Mean of left and right ultrasound measurements were used for analysis. Coefficient of 
variation was 3.5%. The five CUBA machines were calibrated daily with a physical phantom 
and compared to one calcaneus. 
Fracture and fall outcomes 
Participants of EPIC-Norfolk were followed for health events to the present date. Participant 
fracture and fall admissions in England, Wales, and Norfolk hospitals were identified by linking 
via the unique national health service (NHS) number by data linkage with ENCORE (East 
Norfolk Commission Record) [17]. The fracture data for analysis was available up to 31st March 
2016 and were captured after baseline. This method of fracture ascertainment has been 
previously validated [18]. Based on ICD-10 criteria the following hospital admissions for: hip 
fracture (S72.0), falls (W00-W19), and all fracture (S32, S62, S72, and S82) were extracted. 
 
Grouping of variables for analysis 
Categorical variables were grouped into dichotomous variables before univariate analysis: 










(skilled non-manual, manager, professional); educational status as O-level or less (no 
education, O-level) and A-level or more (A-level, degree). Additionally, social class and 
education were made into a single variable: non-manual and O-level or less; manual and O-
level or less; non-manual and A-level or more; and manual and A-level or more. Calcium and 
vitamin D supplements as none, calcium only, vitamin D only, or both. Total blood cholesterol 
was categorised as ≥ 5mmol/L and < 5 mmol/L as defined by Institute for Quality and 
Efficiency in Health Care for hypercholesterolaemia [19]. Total cholesterol level was made 
into a single variable with statin use: no-statin and normal cholesterol; no-statin and 
hypercholesterolaemia; yes-statin and normal cholesterol; yes-statin and 
hypercholesterolaemia. This derivation of combined variables reduced the total number of 
variables  and allow us to control for multiple variables. Age was categorised as <65 years and 
≥65 years and BMI into tertiles: <23, 23-26, and >26 kg/m2.  
Statistical analysis 
Statistical analysis was carried out using the Statistical Package for the Social Sciences for 
Windows version 26.0 (SPSS Inc, Chicago, IL, USA). Participants with missing data were 
excluded from the regression analysis. However, missing participants in the variable “have 
you ever had diabetes during pregnancy” were recoded into the “no” category due to the 
percentage missing being closer to the percentage no category in the “prevalent diabetes”.  
Linear regression tested strength of association between the main predictor: gestational 
diabetes (GDM) and the continuous outcomes of VOS and BUA. For linear regression, multiple 
models were built to better understand which factors - other than GDM - influenced BMD. 
The first model, model A, was built with the variables: GDM, age at baseline, BMI, smoking 
status, activity level, area deprivation index, self-reported stroke, diabetes mellitus 
prevalence, dietary vitamin D and calcium intake, diuretics for > 3months, calcium and vitamin 
D supplement, social class and education, statin and total blood cholesterol, hormone 
therapy, menopausal status. Next, model B, utilised significant variables at 10% significance 
(cut off p = 0.10) from univariate analysis for BUA which was the same as model A minus the 
variables deprivation index, prevalent diabetes mellitus, and dietary calcium. For VOS in 
model B, variables were same as those in BUA except smoking status which was non-
significant at univariate model was removed. Unstandardised beta coefficient (B) was 
calculated with the standard of error (SE) and presented with the p-value for significance of 
the association. 
Cox regression models were constructed to calculate the hazard ratios (HR) for the following 
outcomes: hip fracture, all fractures, and hospitalisations for falls. Other fracture variables 
which violated the proportional hazard assumption were not assessed (wrist fracture, spine 
fracture, and other fracture). Follow up time was calculated from the date of first live birth to 
date of hospital admission for first fracture or first hospitalisation with a fall, for respective 
outcomes. Date of first live birth represented a suitable date for when GDM would have 











constructed utilised for cox regression. HRs are presented with 95% confidence intervals and 
p-values for significance.  
Results 
 
A total of 10,526 women attended the baseline health examination (1993-1997) and 7,478 
attended second health check where skeletal properties using calcaneum ultrasound was 
measured. Therefore, falls and fracture outcomes were assessed in 10,526 women and 
BUA/VOS analysis was based on 7,478 women. 
Table 1 shows the comparison of characteristics of women with GDM to those without; they 
were more likely to be younger (56.7 ± 8.8 and 58.7 ± 9.2, p-value < 0.01) and less likely to 
have prevalent diabetes. Moreover, participants with GDM were less likely to be menopausal 
at the time of enrolment when compared to the control. Other factors such as: BMI, smoking 
status, alcohol intake, level of activity, deprivation index, social class, education, nutritional 
intake, self-reported stroke, and medication usage were not significantly different in the two 
exposure groups (Table 1). Whilst the number of trips, falls and stumbles were not significant 
between the groups, there were significant differences with regards to all fractures and hip 
fractures. 
Gestational diabetes and bone mineral density 
Table 2 shows the results of linear regression for the predictor GDM with the outcomes of 
calcaneus ultrasound VOS (n =7,478) and BUA (n=7,478) unadjusted demonstrated 
significance for VOS and no significance for BUA with a B (SE) of -9.61 (3.81), p=0.012 and  -
2.43 (1.57), and p=0.122 respectively (Table 2). 
Gestational diabetes and fractures 
The follow up time for all fracture, hip fractures, and falls respectively were: median of 52 
years (SD, 10; 550,194 total person years); median of 53 years (SD, 10; 555,491 total person 
years); median of 52 years (SD, 9.9; 548,816 total person years). Number of women identified 
for each outcome was 1266, 582, and 1576 for all fracture, hip fracture, and falls respectively. 
Table 3 shows the HRs and 95% CIs for all fractures, hip fractures, and falls hospitalisations in 
women with GDM using an unadjusted model and model A which controls for same variables 
as linear regression. The outcome all fractures when analysed unadjusted yielded a significant 
HR=1.6 (1.1-2.33) and remained significant after adjustment in model A HR=1.6 (1.09-2.35) as 
seen in Table 3. Hip fractures were significant for both unadjusted model and model A with 
HRs of 2.47 (1.57-3.91) and p<0.001, 2.46(1.54-3.92) and p<0.001, and 2.46 (1.54-3.92) and 
p<0.001. Trips, falls, stumbles did not reach statistical significance unadjusted or in model A 
















In the EPIC Norfolk cohort, gestational diabetes mellitus (GDM) was significantly associated 
with fractures, specifically hip fractures, after adjusting for potential confounding factors. 
Apart from GDM, BMI was the only other significant (p<0.05) variable on cox regression for 
hip fractures where B=-0.19 and SE=0.11. Trips and falls were not significantly associated with 
GDM.  
There were no associations between BUA and VOS measurements and GDM. VOS was only 
significant when unadjusted suggesting other factors were responsible for the result. In 
multivariate analysis, it was noted that out of all the covariates adjusted, BMI (B=1.94, 
SE=0.04), HT (B=-10.6, SE=-0.5), and menopausal status (B=-12.6, SE=0.4) had the strongest 
influence (p<0.05). Calcaneal ultrasound measurements give insight into skeletal properties 
and not BMD. Hence, BMD changes may have occurred given the hip fracture significance. 
The hip and spine are the most sensitive markers of osteoporosis and fragility fractures and 
thus it was hypothesised osteoporosis played a role. It is possible that reduced bone mineral 
density would explain the increased fracture risk in women with history of GDM.   
Strengths and Limitations 
To the best of our knowledge, this is the first cohort study which examined the link between 
gestational diabetes during reproductive age and long-term bone mineral density and 
fracture and falls risk in women. The strength of this study lies in the long follow up period 
after development of GDM which allows for detection of any changes to BMD in the long 
term. The large sample size of the study together with population-based apparently healthy 
community living women where data were collected prospectively strengthen the relevance.  
The use of  validated follow-up methods and our ability to adjust for wide range of 
confounders including menopausal status and hormone therapy also increase the robustness 
of our findings.  
A limitation of this study was the measurements for QUS were made a few years after baseline 
measurements. Within this time period participants could have altered their lifestyles which 
may have influenced their BMD. One of the limitations of this study is the method of 
ascertaining GDM with the question of “have you ever had diabetes during pregnancy” which 
includes the possibility of patients with DM type 1 and 2 answering yes introducing reporting 
bias. However, the National Institute for Health and Care Excellence (NICE) in the UK 
estimates the majority of DM during pregnancy is mainly GDM,  with an incidence of 87.5% 
[20]. In addition, prevalent diabetes at the time of enrolment in those who replied “yes” 
accounted for 0.2% (Table 1) and thus it was unlikely we have many participants who already 











Data collection began in 1997 and patient records would date to before then and the 
definition of gestational diabetes has since changed. Before 1997 there was no World Health 
Organisation (WHO) definition of GDM and different hospitals utilised different cut-off points 
for blood glucose, therefore acquisition of GDM status would still not be as accurate through 
hospital records. 
It is recognised that risk factors for GDM exist that do warrant screening during pregnancy 
such as: BMI >30 kg/m2, previous GDM, family history of GDM, and an ethnicity with high 
prevalence of diabetes mellitus [21]. GDM is sometimes classified into the two categories true 
GDM and pre-existing diabetes based on the International Association of Diabetes and 
Pregnancy Study Groups consensus [22]. True GDM is diagnosed in pregnancy and resolves 
after pregnancy, however pre-existing diabetes tends to be present before and after as well 
as requiring insulin therapy. Knowing that classifications and differing cut-offs for GDM exist, 
these are liable to affect numbers in the literature throughout the years and makes the 
studying the effects of GDM difficult. 
We were unable to control for use of bone protection during the follow up and as such did 
not adjust in our analyses. However, inability to control for such co-variate is likely to produce 
attenuation in effect size for the relationship and thus observed effects are likely an 
underestimation. 
Comparison with literature 
To the best of our knowledge, the only other study looking at the association between BMD 
and GDM came from work by Kee et al. [6] in which they measured BMD of women with 
gestational diabetes during pregnancy at 20 and 36 weeks gestation without further follow 
up after pregnancy. The authors concluded that the decrease in BMD they observed during 
pregnancy was due to physiological changes and that factors such as nutrition may have a 
role. The differing results of Kee et al. with our study could be explained by the differences in 
follow up and our ability to control for dietary covariates and supplements in the statistical 
model.  
To date no studies have been conducted on GDM and fracture risk, however it is well 
established that both type 1 and 2 diabetes mellitus are associated with an increased fracture 
risk [13]. 
 
Interpretation of findings 
Diet is linked to both BMI and GDM and could be the driving force behind the strong 
association. BMD loss after GDM exists in this sample in those who have an increased BMI 
and remains unclear for the rest. An increased hip fracture risk remained after adjustment for 
covariates and no other studies exist to confirm the result. The exact mechanism for hip 











the use of a prospective study and DEXA for measuring BMD. Another mechanism explaining 
this finding could be patients developing type 2 DM later in life, and therefore retinopathy 
and neuropathy precipitating the fracture. This would explain the strong association of 
increased BMI with BUA/VOS in both the univariate and multivariate analysis. 
Despite the strong link between development of type 2 diabetes mellitus in later life for GDM, 
the GDM group were less likely to have prevalent diabetes (Table 1). It could be that there 
remains the possibility of a pre-diabetic state in participants or a diagnosis given after baseline 
given the strong evidence of association between GDM and type 2 diabetes mellitus. 
Clinical and research implications  
Effect of GDM on BMD remains an under researched area and its increasing risk to fractures 
and falls may warrant further follow up. Follow up would include typical advice to reduce risk 
of type 2 DM and cardiovascular risk as well as a DEXA scan after menopause to identify those 
at high risk. Lifestyle advice in terms of appropriate diet and increased physical activity should 
maintain or increase BMD and mitigate the risks of fractures. Future research studies 
investigating fracture risk in those with history GDM would require larger cohorts.  
Conclusion 
This study aimed to investigate the link between GDM and BMD, fractures, and falls in the 
EPIC cohort. It was found that a history of GDM increased risk of hip fracture and falls. There 
is currently no literature investigating the association between GDM and long-term fracture 
risk and our study provides better understanding of this relationship. Further research is 
required to gain deeper insight regarding the relationship between GDM, BMD and  fractures.  
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Table 1.  Baseline characteristics of 10,526 women in EPIC-NORFOLK aged 40-78 at first 
health check (1993-1997) according to diabetes in pregnancy status 
 GDM 
n = 183 
No GDM 
n = 10,343 
p-value 
Age, years 56.7 (8.8) 58.7 (9.2) 0.004 

















Alcohol, g 5.0 (8.0) 5.7 (8.5) 0.331 













































































Dietary vitamin D, μg 3.4 (1.9) 3.5 (1.9) 0.730 
Dietary calcium, mg 
 
969.0 (272.4) 991.6 (288.6) 0.292 






























Phosphorus, mg 1443.1 (343.2) 
 
1456.2 (362.2) 0.626 
Protein, g 81.0 (19.5) 81.5 (20.8) 0.770 
Total Cholesterol, 
mmol/L 





























Systolic BP, mmHg 131.3 (18.9) 133.6 (18.7) 0.101 

























































































































































Data presented as mean (standard deviation) for continuous and number (percentage) for 
categorical.BMI: body mass index, BP: blood pressure, ACE: angiotensin converting enzyme, 













Table 2. Linear regression for GDM with BMD outcomes 
 
Model A: diabetes during pregnancy, age at baseline, BMI, smoking status, activity level, area 
deprivation index, self-reported stroke, diabetes mellitus prevalence, vitamin D nutrition, 
calcium nutrition, diuretics for > 3months, calcium and vitamin D supplement, social class and 
education, statin and total blood cholesterol, HT, menopausal status. 
Model B: significant variables from univariate analysis 
 
  
 B SE p-value 
BUA (dB/MHz) 
n = 7478 
   
Unadjusted -2.23 1.56 0.153 
Model A -0.37 1.40 0.793 
Model B -0.438 1.39 0.752 
VOS (m/s) 
n = 7478 
   
Unadjusted -9.61 3.81 0.012 
Model A -5.41 3.48 0.12 











Table 3. Cox regression for GDM with fracture outcomes 
Model A: diabetes during pregnancy, age at baseline, BMI, smoking status, activity level, area 
deprivation index, self-reported stroke, diabetes mellitus prevalence, vitamin D nutrition, 
calcium nutrition, diuretics for > 3months, calcium and vitamin D supplement, social class and 
education, statin and total blood cholesterol, HT, menopausal status. 
 
 Hazard ratio (95%CI) p-value 
Trips, falls, stumbles 
n = 1576 
  
Unadjusted 1.22 (0.83-1.79) 0.304 
Model A 1.17 (0.79-1.74) 0.427 
All fractures 
n = 1266 
  
Unadjusted 1.60 (1.10-2.33) 0.014 
Model A 1.60 (1.09-2.35) 0.017 
Hip fractures 
n = 582 
  
Unadjusted 2.47 (1.57-3.91) <0.001 
Model A 2.46 (1.54-3.92) <0.001 
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